These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10871311)

  • 21. Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia.
    Kojima J; Nakajima K; Ochiai M; Nakayama K
    Methods Find Exp Clin Pharmacol; 1997 May; 19(4):245-51. PubMed ID: 9228650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the effect of ganstigmine (CHF2819) on amyloid precursor protein metabolism in SH-SY5Y neuroblastoma cells.
    Mazzucchelli M; Porrello E; Villetti G; Pietra C; Govoni S; Racchi M
    J Neural Transm (Vienna); 2003 Aug; 110(8):935-47. PubMed ID: 12898348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
    Scali C; Casamenti F; Bellucci A; Costagli C; Schmidt B; Pepeu G
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1067-80. PubMed ID: 12111444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbofuran-induced neurochemical and neurobehavioral alterations in rats: attenuation by N-acetylcysteine.
    Kamboj A; Kiran R; Sandhir R
    Exp Brain Res; 2006 Apr; 170(4):567-75. PubMed ID: 16307259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evaluation of phenyl-carbamates as CNS-selective acetylcholinesterase inhibitors.
    Weinstock M; Razin M; Chorev M; Enz A
    J Neural Transm Suppl; 1994; 43():219-25. PubMed ID: 7884403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible interaction of cholinergic and GABAergic systems between MS and CA1 upon memory acquisition in rats.
    Yousefi B; Nasehi M; Khakpai F; Zarrindast MR
    Behav Brain Res; 2012 Dec; 235(2):231-43. PubMed ID: 22909986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of SDZ ENA 713, novel acetyl cholinesterase inhibitor, on learning of rats with basal forebrain lesions.
    Niigawa H; Tanimukai S; Takeda M; Hariguchi S; Nishimura T
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):171-86. PubMed ID: 7708929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology.
    Chaudhaery SS; Roy KK; Shakya N; Saxena G; Sammi SR; Nazir A; Nath C; Saxena AK
    J Med Chem; 2010 Sep; 53(17):6490-505. PubMed ID: 20684567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®.
    Kehr J; Yoshitake S; Ijiri S; Koch E; Nöldner M; Yoshitake T
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S25-34. PubMed ID: 22784425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats.
    Piri M; Rostampour M; Nasehi M; Zarrindast MR
    Neuroscience; 2013 Nov; 252():460-7. PubMed ID: 23933216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Sang ZP; Qiang XM; Li Y; Wu B; Zhang H; Zhao MG; Deng Y
    Chem Biol Drug Des; 2015 Nov; 86(5):1168-77. PubMed ID: 25941042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrrolidine dithiocarbamate protects against scopolamine-induced cognitive impairment in rats.
    Abd-El-Fattah MA; Abdelakader NF; Zaki HF
    Eur J Pharmacol; 2014 Jan; 723():330-8. PubMed ID: 24315930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat.
    Dronfield S; Egan K; Marsden CA; Green AR
    J Psychopharmacol; 2000; 14(3):275-9. PubMed ID: 11106308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptotanshinone, an acetylcholinesterase inhibitor from Salvia miltiorrhiza, ameliorates scopolamine-induced amnesia in Morris water maze task.
    Wong KK; Ho MT; Lin HQ; Lau KF; Rudd JA; Chung RC; Fung KP; Shaw PC; Wan DC
    Planta Med; 2010 Feb; 76(3):228-34. PubMed ID: 19774505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission.
    Amenta F; Tayebati SK; Vitali D; Di Tullio MA
    Mech Ageing Dev; 2006 Feb; 127(2):173-9. PubMed ID: 16297435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
    Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.